Galapagos Buys GSK R&D Site | September 20, 2010 Issue - Vol. 88 Issue 38 | Chemical & Engineering News
Volume 88 Issue 38 | p. 14 | Concentrates
Issue Date: September 20, 2010

Galapagos Buys GSK R&D Site

Department: Business
Keywords: GSK, Galapagos, Aptuit, R&D

GlaxoSmithKline is selling its Zagreb, Croatia, R&D facility to Belgian contract research organization Galapagos. The 130 employees at the site will transfer to Galapagos, which will in turn provide GSK with R&D services worth $18 million over a three-year period. In July, GSK sold its Verona, Italy, R&D center to Aptuit, which agreed to take on the 500 employees at the lab and continue providing R&D services for GSK.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment